Total Funding
53
49
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
52147
Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.
David Jorden: Interim CEO & Bord of DirectorsPast Role: Fayez Sarofim & Co., Principal
Jennifer West: Co-Founder & Bord of DirectorsPast Role: RichRelevance, Former Professor & Chairperson
About the Company
Nanospectra Biosciences is a medical device company, engages in developing and commercializing particle-based therapies for the selective and precise thermal destruction of solid tumors. The company provides AuroLase Therapy, a medical device that is applicable to the ablation of various solid tumors. It also offers research-use-only nanoparticles
with specific optical characteristics.
Nanospectra Biosciences was founded in 2002 and is based in Houston, Texas.
Women Founded
